Provided are anti tumor conjugates which consist of folate or analogues thereof linkers and antibodies such as Immunoglobulin G. The linker comprises glutathione cysteamine or cysteine residue and further comprises N hydroxysuccinimide. The conjugates target folate receptor positive tumor cells. Also provided are preparation methods and anti tumor use of the conjugates.
